Suppr超能文献

利用人诱导多能干细胞来源的类器官对T细胞介导的自身免疫性垂体疾病进行建模。

Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid.

作者信息

Kanie Keitaro, Ito Takeshi, Iguchi Genzo, Matsumoto Ryusaku, Muguruma Keiko, Urai Shin, Kitayama Shuichi, Bando Hironori, Yamamoto Masaaki, Fukuoka Hidenori, Ogawa Wataru, Kaneko Shin, Takahashi Yutaka

机构信息

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.

Shin Kaneko Laboratory, Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Kyoto, Japan.

出版信息

Nat Commun. 2025 Aug 25;16(1):7900. doi: 10.1038/s41467-025-63183-x.

Abstract

Anti-pituitary-specific transcription factor (PIT)-1 hypophysitis is an autoimmune disease characterized by hormone secretion impairment from PIT-1-expressing pituitary cells, accompanied by malignancies with ectopic PIT-1 expression. Cytotoxic T cells (CTL) targeting PIT-1-positive cells have been implicated in disease development, yet direct evidence is lacking. As human leukocyte antigen (HLA)-matching is required for modeling T cell-mediated autoimmune diseases, we employ induced pluripotent stem cells (iPSC) to generate pituitary organoids harboring the patients' HLA haplotype and coculture the organoids with PIT-1-reactive CTLs isolated from the patients' peripheral blood mononuclear cells. The coculture demonstrates specific CTL-mediated cytotoxicity against PIT-1-positive cells exclusively in autologous conditions, with this cytotoxicity inhibited by immunosuppressive agents such as dexamethasone and cyclosporin A. Multiple combinations of epitopes, CTLs, and HLA molecules are responsible for pathogenesis. These data demonstrate CTL-mediated autoimmunity in anti-PIT-1 hypophysitis and highlight the potential application of this strategy for other T cell-mediated autoimmune diseases.

摘要

抗垂体特异性转录因子(PIT)-1垂体炎是一种自身免疫性疾病,其特征为表达PIT-1的垂体细胞激素分泌受损,并伴有异位表达PIT-1的恶性肿瘤。靶向PIT-1阳性细胞的细胞毒性T细胞(CTL)与疾病发展有关,但缺乏直接证据。由于模拟T细胞介导的自身免疫性疾病需要人类白细胞抗原(HLA)匹配,我们利用诱导多能干细胞(iPSC)生成携带患者HLA单倍型的垂体类器官,并将这些类器官与从患者外周血单个核细胞中分离出的PIT-1反应性CTL共培养。共培养显示,仅在自体条件下,CTL对PIT-1阳性细胞具有特异性介导的细胞毒性,这种细胞毒性可被地塞米松和环孢素A等免疫抑制剂抑制。表位、CTL和HLA分子的多种组合与发病机制有关。这些数据证明了CTL介导的抗PIT-1垂体炎自身免疫性,并突出了该策略在其他T细胞介导的自身免疫性疾病中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d82e/12378982/1c00117e34a6/41467_2025_63183_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验